Deep-pocketed financiers have actually embraced a bearish method towards Amgen AMGN, and it’s something market gamers should not disregard. Our tracking of public alternatives records at Benzinga revealed this considerable relocation today. The identity of these financiers stays unidentified, however such a considerable relocation in AMGN normally recommends something huge will occur.
We obtained this info from our observations today when Benzinga’s alternatives scanner highlighted 11 amazing alternatives activities for Amgen. This level of activity runs out the common.
The basic state of mind amongst these heavyweight financiers is divided, with 45% leaning bullish and 54% bearish. Amongst these noteworthy alternatives, 5 are puts, amounting to $314,429, and 6 are calls, totaling up to $210,119.
Anticipated Rate Motions
Based upon the trading activity, it appears that the considerable financiers are going for a rate area extending from $210.0 to $290.0 for Amgen over the current 3 months.
Insights into Volume & & Open Interest
In today’s trading context, the typical open interest for alternatives of Amgen stands at 455.0, with an overall volume reaching 765.00. The accompanying chart marks the development of both call and put choice volume and open interest for high-value sell Amgen, positioned within the strike rate passage from $210.0 to $290.0, throughout the last thirty days.
Amgen 30-Day Choice Volume & & Interest Photo
Largest Options Trades Observed:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Rate | Strike Rate | Overall Trade Rate | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | PUT | TRADE | BEARISH | 05/16/25 | $ 10.9 | $ 8.45 | $ 10.0 | $ 290.00 | $ 120.0 K | 2.1 K | 120 |
| AMGN | PUT | TRADE | BULLISH | 07/18/25 | $ 17.4 | $ 16.6 | $ 16.6 | $ 280.00 | $ 79.6 K | 814 | 16 |
| AMGN | CALL | TRADE | BULLISH | 05/30/25 | $ 8.55 | $ 7.85 | $ 8.55 | $ 275.00 | $ 47.0 K | 1 | 110 |
| AMGN | PUT | SWEEP | BEARISH | 05/02/25 | $ 4.6 | $ 4.15 | $ 4.6 | $ 280.00 | $ 45.5 K | 667 | 225 |
| AMGN | CALL | TRADE | BEARISH | 01/15/27 | $ 87.0 | $ 82.5 | $ 83.5 | $ 210.00 | $ 41.7 K | 6 | 5 |
About Amgen
Amgen is a leader in biotechnology-based human therapies. Flagship drugs consist of red cell boosters Epogen and Aranesp, body immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory illness. Amgen presented its very first cancer restorative, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (authorized 2010) and Evenity (2019 ). The acquisition of Onyx Pharmaceuticals boosted the company’s restorative oncology portfolio with Kyprolis. Current launches consist of Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought numerous rare-disease drugs, consisting of thyroid eye illness drug Tepezza. Amgen likewise has a growing biosimilar portfolio.
Having actually taken a look at the alternatives trading patterns of Amgen, our attention now turns straight to the business. This shift enables us to explore its present market position and efficiency
Amgen’s Current Market Status
- Trading volume stands at 1,313,938, with AMGN’s rate down by -1.6%, placed at $279.24.
- RSI signs reveal the stock to be is presently neutral in between overbought and oversold.
- Incomes statement anticipated in 95 days.
What Experts Are Stating About Amgen
An overall of 2 expert experts have actually provided their take on this stock in the last thirty days, setting a typical rate target of $324.5.
Turn $1000 into $1270 in simply 20 days?
20-year professional alternatives trader exposes his one-line chart strategy that reveals when to purchase and offer. Copy his trades, which have actually had balanced a 27% revenue every 20 days. Click on this link for gain access to
* An expert from Morgan Stanley continues with their Equal-Weight score on Amgen, keeping a target rate of $330.
* Constant in their assessment, an expert from UBS keeps a Neutral score on Amgen with a target rate of $319.
Options trading provides greater dangers and possible benefits. Astute traders handle these dangers by continuously informing themselves, adjusting their methods, keeping an eye on numerous signs, and keeping a close eye on market motions. Stay notified about the most recent Amgen alternatives trades with real-time notifies from Benzinga Pro.